Latest News about PTGX
Recent news which mentions PTGX
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
May 09, 2025
From Benzinga
From Benzinga
D-Wave Quantum And IonQ Are Among Top Mid-Cap Stock Gainers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
March 16, 2025
From Benzinga
From Benzinga
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
March 10, 2025
From Benzinga
From Benzinga
From Benzinga
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
November 22, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
From Benzinga
Tickers
PTGX
From InvestorPlace
From Benzinga
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
July 24, 2024
From Benzinga
3 Growth Stocks No One Is Watching (But They Should Be)
July 11, 2024
From InvestorPlace
The 3 Best Biotech Stocks to Buy in June 2024
June 05, 2024
From InvestorPlace
Tickers
PTGX
From InvestorPlace
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?
February 01, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 31, 2024
From Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
From Motley Fool
The Latest Analyst Ratings for Protagonist Therapeutics
November 03, 2023
Tickers
PTGX
From Benzinga
What 6 Analyst Ratings Have To Say About Protagonist Therapeutics
September 25, 2023
Tickers
PTGX
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.